Journal of geriatric oncology Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Smartphone application for longitudinal home gait speed measurement in older adults with blood cancers: A feasibility and acceptability study..  -. 2024
• Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study..  15:-. 2024
• Trends in the use of granulocyte colony stimulating factors for older patients with cancer, 2010 to 2019..  15:-. 2024
• Identification of older adults with Alzheimer's and related dementias among patients newly diagnosed with cancer: A comparison of methodological approaches..  15:-. 2024
• Age and postoperative swallowing function in patients treated for advanced oral cancer: A retrospective study..  15:-. 2024
• Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)..  15:-. 2024
• Prognostic awareness and willingness to explore prognosis in older adults with cancer..  15:-. 2024
• Physician-level variation in axillary surgery in older adults with T1N0 hormone receptor-positive breast cancer: A retrospective population-based cohort study..  15:-. 2024
• Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia..  15:-. 2024
• Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report..  15:-. 2024
• The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study..  15:-. 2024
• Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study..  15:-. 2024
• Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review..  15:-. 2024
• Patient-oncologist discussion of treatment decisions: Exploring the role of a patient-centered communication tool for older adults with acute myeloid leukemia and their caregivers..  15:-. 2024
• Unipedal stance time is associated with fall outcomes in older chemotherapy-treated cancer survivors: A retrospective study..  15:-. 2023
• Epigenetic and inflammatory markers in older adults with cancer: A Young International Society of Geriatric Oncology narrative review..  15:-. 2023
• Digital health in geriatric oncology: A Young International Society of Geriatric Oncology review..  14:-. 2023
• Modifiable fall risk factors among older adults with advanced cancer: Secondary analysis of a cluster-randomized clinical trial..  14:-. 2023
• Executive function is associated with balance and falls in older cancer survivors treated with chemotherapy: A cross-sectional study..  14:-. 2023
• Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)..  15:-. 2023
• The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer..  14:-. 2023
• Association of cardiovascular disease with health-related quality of life among older women with early-stage breast cancer undergoing adjuvant endocrine therapy..  14:-. 2023
• Stigmatizing language in caring for older adults with cancer: Common patterns of use and mechanisms to change the culture..  14:-. 2023
• A usability and participatory design study for GeRI, an open-source, remote cancer treatment toxicity and frailty monitoring platform for older adults..  15:-. 2023
• "Celebrating Resilience": A review of abstracts on functional resilience at the International Society of Geriatric Oncology 2022 annual meeting..  14:-. 2023
• Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia..  14:-. 2023
• Marital status, frailty, and survival in older adults with blood cancer..  14:-. 2023
• A pilot study of adherence to lenalidomide among older patients with multiple myeloma..  14:-. 2023
• SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer..  14:-. 2023
• Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia..  14:-. 2023
• Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study..  14:-. 2023
• Lessons learned from organizing International Society of Geriatric Oncology (SIOG) geriatric assessment workshops..  14:-. 2023
• Implementing 4-meter gait speed as a routine vital sign in a thoracic surgery clinic..  14:-. 2023
• The association between religiosity, mental health, and cognitive functioning among older adults with hematologic malignancies..  14:-. 2023
• The role of self-perceived age in older adults considering adjuvant chemotherapy..  14:-. 2023
• Treatment decision conversations, symptoms, and functional status in older adults with advanced cancer: An exploratory study utilizing mixed methods..  14:-. 2022
• Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee..  14:-. 2022
• Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia..  14:-. 2022
• End-of-life care trajectories among older adults with lung cancer..  14:-. 2022
• Knowledge, beliefs, and misconceptions about palliative care among older adults with cancer..  14:-. 2022
• 'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer..  14:-. 2022
• Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes..  14:-. 2022
• Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study..  14:-. 2022
• Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study..  13:1230-1235. 2022
• Change in four measures of physical function among older adults during lung cancer treatment: A mixed methods cohort study..  14:-. 2022
• Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study..  13:1132-1140. 2022
• Resilience in older adults with cancer: A scoping literature review..  14:-. 2022
• Updated International Society of Geriatric Oncology COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer..  13:1054-1057. 2022
• Comparing the association between multiple chronic conditions, multimorbidity, frailty, and survival among older cancer patients..  13:1244-1252. 2022
• Development of an intervention influencing activity limitations in older breast cancer survivors: A modified Delphi study..  13:1031-1037. 2022
• Characterization of older adults with cancer seeking acute emergency department care: A prospective observational study..  13:943-951. 2022
• Corrigendum to "Effects of a mixed exercise program on cancer related-fatigue and health-related quality of life in oncogeriatric patients: A feasibility study" [Journal of Geriatric Oncology 12 Issue 6 (2021) 915-921]..  13:-. 2022
• Use of geriatric assessment in cancer clinical trials: A systematic review..  13:907-913. 2022
• Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders..  13:987-996. 2022
• Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia..  13:871-874. 2022
• Caregiver-oncologist prognostic concordance, caregiving esteem, and caregiver outcomes..  13:828-833. 2022
• Polypharmacy in older adults with cancer undergoing radiotherapy: A review..  13:778-783. 2022
• Geriatric assessment in older adults with Non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper..  13:572-581. 2022
• Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies..  13:594-599. 2022
• Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma..  13:614-623. 2022
• "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology..  13:606-613. 2022
• Overview of Sankey flow diagrams: Focusing on symptom trajectories in older adults with advanced cancer..  13:742-746. 2022
• Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma..  13:635-643. 2022
• Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2)..  13:545-553. 2021
• An overview of chemotherapy toxicity prediction tools in older adults with cancer: A young international society of geriatric oncology and nursing and allied health initiative..  13:521-525. 2021
• Impact of non-pharmacological interventions on activity limitations and participation restrictions in older breast cancer survivors: A scoping review..  13:132-142. 2021
• Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model..  13:176-181. 2021
• Feasibility of implementing an exercise intervention in older adults with hematologic malignancy..  13:234-240. 2021
• Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status..  13:182-189. 2021
• Polypharmacy and frailty in older adults evaluated at a multidisciplinary geriatric-thoracic clinic prior to surgery..  13:249-252. 2021
• Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)..  13:20-26. 2021
• Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment..  12:1208-1213. 2021
• Improving personalized treatment decision-making for older adults with cancer: The necessity of eliciting patient preferences..  13:1-3. 2021
• Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis..  12:1022-1030. 2021
• The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core..  12:1164-1165. 2021
• Caregiving burden of informal caregivers of older adults with advanced cancer: The effects of rurality and education..  12:1015-1021. 2021
• An introduction to machine learning for clinicians: How can machine learning augment knowledge in geriatric oncology?.  12:1159-1163. 2021
• Objective performance tests of cognition and physical function as part of a virtual geriatric assessment..  12:1256-1258. 2021
• Effects of a mixed exercise program on cancer related-fatigue and health-related quality of life in oncogeriatric patients: A feasibility study..  12:915-921. 2021
• Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancer..  12:724-730. 2021
• The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer..  12:848-850. 2021
• Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study..  12:909-914. 2021
• Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer..  12:752-758. 2021
• Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer..  12:813-819. 2021
• Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report..  12:860-862. 2021
• Prevalence of functional limitations and their associations with systemic cancer therapy among older adults in nursing homes with advanced non-small cell lung cancer..  12:765-770. 2021
• The aging microbiome and response to immunotherapy: Considerations for the treatment of older adults with cancer..  12:985-989. 2021
• Perspectives on Geriatric Oncology Research Presented at the 2020 San Antonio Breast Cancer Symposium..  12:483-488. 2021
• Changes in functional status associated with radiation for prostate cancer in older veterans..  12:808-812. 2020
• Prevalence and predictors of depressive symptoms in older adults with cancer..  12:618-622. 2020
• Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper..  12:499-507. 2020
• Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer..  12:749-751. 2020
• Corrigendum to 'Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer' [Journal of Geriatric Oncology 11 (4) (2020) 652-659]..  12:-. 2020
• Perspectives on functional status in older adults with cancer: An interprofessional report from the International Society of Geriatric Oncology (SIOG) nursing and allied health interest group and young SIOG..  12:658-665. 2020
• Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients..  12:585-591. 2020
• Opportunities for quality improvement in the morbidity pattern of older adults undergoing pulmonary lobectomy for cancer..  12:416-421. 2020
• Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)..  12:563-571. 2020
• Let's get it on: Addressing sex and intimacy in older cancer survivors..  12:312-315. 2020
• Never too old to learn new tricks: Surveying Canadian healthcare professionals about learning needs in caring for older adults with cancer..  12:262-273. 2020
• Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies..  12:235-238. 2020
• Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meeting..  11:1324-1328. 2020
• Did quality of life for older cancer survivors improve with the turn of the century in the United States?.  12:102-105. 2020
• Multidisciplinary telemedicine and the importance of being seen..  11:1349-1351. 2020
• Health-related and sociodemographic factors associated with physical frailty among older cancer survivors..  12:96-101. 2020
• Geriatric oncology research presented at the ASCO GI 2020 symposium: Young international society of geriatric oncology perspective paper..  11:1182-1186. 2020
• Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective..  11:1175-1181. 2020
• Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer..  11:1118-1124. 2020
• Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States..  11:753-760. 2020
• Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma..  11:764-768. 2020
• Development of a telehealth geriatric assessment model in response to the COVID-19 pandemic..  11:761-763. 2020
• The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort..  11:1157-1160. 2020
• Speeding the dissemination and implementation of geriatric assessment: What we can learn from the business world..  11:1170-1174. 2020
• Severe functional limitation due to pain & emotional distress and subsequent receipt of prescription medications among older adults with cancer..  11:960-968. 2020
• Management of bladder cancer in older patients: Position paper of a SIOG Task Force..  11:1043-1053. 2020
• Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper..  11:735-739. 2020
• Perspectives on geriatric oncology research presented at the 2019 International Society of Geriatric Oncology Annual Meeting: Young International Society of Geriatric Oncology report..  11:549-552. 2020
• "Radiotherapy for older women (ROW)": A risk calculator for women with early-stage breast cancer..  11:850-859. 2019
• Relationships of self-perceived age with geriatric assessment domains in older adults with cancer..  11:1006-1010. 2019
• Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer..  11:652-659. 2019
• Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing..  11:297-303. 2019
• Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer..  11:284-289. 2019
• Use of geriatric assessment in hematopoietic cell transplant..  11:225-236. 2019
• Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials..  11:451-454. 2019
• A novel geriatric assessment tool that predicts postoperative complications in older adults with cancer..  11:866-872. 2019
• Barriers to palliative and hospice care utilization in older adults with cancer: A systematic review..  11:8-16. 2019
• Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study..  11:290-296. 2019
• Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance)..  11:107-113. 2019
• Developing sustainable national infrastructure supporting high-impact research to improve the care of older adults with cancer: A Delphi investigation of geriatric oncology experts..  11:338-342. 2019
• Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper..  11:217-224. 2019
• Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper..  11:237-243. 2019
• Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis..  11:316-319. 2019
• The association between social support and chemotherapy-related toxicity in older patients with cancer..  11:274-279. 2019
• Developing a clinical and biological measures of aging core: Cancer and Aging Research Group infrastructure..  11:343-346. 2019
• The role of comprehensive geriatric assessment in radiation oncology..  11:194-196. 2019
• Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper..  11:203-211. 2019
• A story of connection: A tribute to Arti Hurria, MD..  11:164-165. 2019
• Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core..  11:347-349. 2019
• Do what you love. Love what you do. Dr. Arti Hurria's trailblazing transdisciplinary legacy..  11:158-159. 2019
• Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults..  11:395-398. 2019
• Cores for geriatric oncology infrastructure in the Cancer and Aging Research Group: Biostatistics, epidemiology, and research design (the analytics core)..  11:355-358. 2019
• Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core..  11:350-354. 2019
• Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting..  10:998-1002. 2019
• Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group..  10:994-997. 2019
• Telehealth in geriatric oncology: A novel approach to deliver multidisciplinary care for older adults with cancer..  11:197-199. 2019
• Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology..  11:179-183. 2019
• Breast cancer and aging: Standing on the shoulders of a giant..  11:212-216. 2019
• Geriatric assessment and treatment outcomes in older adults with cancer receiving immune checkpoint inhibitors..  11:523-528. 2019
• Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD..  11:335-337. 2019
• Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer..  10:980-986. 2019
• Catching Arti's kisses..  11:147-148. 2019
• Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy..  11:423-430. 2019
• Prevalence and factors associated with malnutrition in older patients with cancer..  10:763-769. 2019
• Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia..  11:410-416. 2019
• Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis..  10:874-883. 2019
• Clinical prognostic model for older patients with advanced non-small cell lung cancer..  10:555-559. 2019
• From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults..  10:384-388. 2019
• Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer..  10:669-672. 2019
• Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper..  10:186-191. 2019
• Perspectives on geriatric oncology research presented at the 2018 San Antonio Breast Cancer Symposium..  10:192-195. 2019
• ASCO gastrointestinal cancers symposium: Perspectives on older adults with gastrointestinal malignancies..  10:371-373. 2019
• Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology..  11:557-565. 2019
• PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper..  10:337-345. 2018
• Characterizing cancer cachexia in the geriatric oncology population..  10:415-419. 2018
• Improving implementation of psychological interventions to older adult patients with cancer: Convening older adults, caregivers, providers, researchers..  9:423-429. 2018
• Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study..  10:265-271. 2018
• Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper..  10:389-397. 2018
• Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant..  10:479-485. 2018
• Functional trajectories before and after a new cancer diagnosis among community-dwelling older adults..  10:60-67. 2018
• Communication about geriatric assessment domains in advanced cancer settings: "Missed opportunities"..  10:68-73. 2018
• Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)..  9:501-506. 2018
• A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging..  9:287-290. 2018
• Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)..  9:321-328. 2018
• Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?.  9:296-301. 2018
• Exercise for managing cancer- and treatment-related side effects in older adults..  9:405-410. 2018
• The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)..  9:221-227. 2018
• Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers..  9:534-539. 2018
• Neurocognitive deficits in older patients with cancer..  9:482-487. 2018
• Elucidating the associations between sleep disturbance and depression, fatigue, and pain in older adults with cancer..  9:464-468. 2018
• The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)..  9:228-234. 2017
• Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index..  9:81-83. 2017
• Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults..  8:417-420. 2017
• Motivation and mortality in older women with early stage breast cancer: A longitudinal study with ten years of follow-up..  8:133-139. 2016
• Association between renal function and chemotherapy-related toxicity in older adults with cancer..  8:96-101. 2016
• Polypharmacy and potentially inappropriate medication use in geriatric oncology..  7:346-53. 2016
• Physical resilience of older cancer survivors: An emerging concept..  7:471-478. 2016
• Chemotherapy-related cognitive impairment in older patients with cancer..  7:270-80. 2016
• Gaps in nutritional research among older adults with cancer..  7:281-92. 2016
• Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research..  7:242-8. 2016
• Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI..  7:225-33. 2016
• Survivorship care for older adults with cancer: U13 conference report..  7:305-12. 2016
• How should older adults with cancer be evaluated for frailty?.  8:8-15. 2016
• Understanding cognition in older patients with cancer..  7:258-69. 2016
• How do I best manage insomnia and other sleep disorders in older adults with cancer?.  7:413-421. 2016
• Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting..  7:293-304. 2016
• Trends in end-of-life cancer care in the Medicare program..  7:116-25. 2016
• Poor persistence with hormonal therapy among women with breast cancer..  7:154-7. 2016
• Comorbidity in older adults with cancer..  7:249-57. 2015
• Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011..  7:15-23. 2015
• Symptoms, weight loss, and physical function in a lifestyle intervention study of older cancer survivors..  6:424-32. 2015
• Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors..  6:133-40. 2015
• Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions..  6:93-100. 2014
• Systematic review of falls in older adults with cancer..  6:70-83. 2014
• Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment..  5:343-51. 2014
• Characteristics and treatment options of elderly Chinese patients with cancer as determined by Comprehensive Geriatric Assessment (CGA)..  5:171-8. 2014
• A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901..  4:353-61. 2013
• A new approach to understanding racial disparities in prostate cancer treatment..  4:1-8. 2013
• The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer..  4:9-18. 2013
• Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803)..  3:82-89. 2012
• Does Life Expectancy Affect Treatment of Women Aged 80 and Older with Early Stage Breast Cancers?.  3:8-16. 2012
• Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting..  1:40-44. 2010

Identity

International Standard Serial Number (ISSN)

• 1879-4076